← brief for 2026-08-10 · Slowing decline

NKF Live: Biogen PREVAIL Trial

Video No results yet Not peer reviewed

Key takeaways

This is a patient webinar from the National Kidney Foundation about the PREVAIL trial, which is testing a drug called felzartamab in adults with IgA nephropathy, a disease where the immune system harms the kidney's filters. It explains how the trial works and how to take part. There are no results yet, and the program is paid for by the drug's maker, Biogen.

Who did this work

National Kidney Foundation (YouTube channel)

Source

Video · YouTube, National Kidney Foundation · 2026-08-04
https://www.youtube.com/watch?v=EliHmgtxJC8